Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biotime Inc (BTX)

Biotime Inc (BTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biotime Inc 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 USA

P: 510-521-3390

Description:

BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine. The foundation of its core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. BioTime's research and other activities have resulted, over time, in the creation of other subsidiaries that address other non-therapeutic market opportunities such as cancer diagnostics, drug development and cell research products, and mobile health software applications.

Key Statistics

Overview:

Market Capitalization, $K 137,657
Shares Outstanding, K 149,643
Annual Sales, $ 4,990 K
Annual Net Income, $ -45,990 K
Last Quarter Sales, $ 930 K
Last Quarter Net Income, $ 39,310 K
60-Month Beta 2.77
% of Insider Shareholders 30.80%
% of Institutional Shareholders 46.17%
Float, K 103,553
% Float 69.20%

Growth:

1-Year Return -60.18%
3-Year Return -70.52%
5-Year Return -69.13%
5-Year Revenue Growth 12.64%
5-Year Earnings Growth 61.73%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/08/19
Earnings Per Share ttm 0.10
EPS Growth vs. Prev Qtr -120.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.080 on 12/15/03
Dividend Payout Ratio 128.88

BTX Ratios

Ratio
Price/Earnings ttm 9.90
Price/Earnings forward -8.11
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 7.94
Return-on-Assets (Before Tax) 7.28
Profit Margin % -921.64
Net Margin % -400.58
Debt/Equity 0.03
Price/Sales 29.70
Price/Cash Flow N/A
Price/Book 0.85
Book Value/Share 1.08
Interest Coverage -67.38
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar